Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for FitLife Brands Inc. (FTLF : NSDQ)
 
 • Company Description   
FitLife Brands, Inc. provides nutritional and fitness enhancement products for health-conscious consumers. The Company's product includes Pump Fuel, ACG3, Core Fuel, Embrace Extreme, Lipo Rush, Cardio Cuts, Dr. Detox, Dr. Cholesterol and Dr. Joints. It market and sells product directly to athletic facilities, gyms and independent retailers. Fitlife Brands, Inc., formerly known as Bond Laboratories Inc., is headquartered in Omaha, Nebraska.

Number of Employees: 39

 
 • Price / Volume Information   
Yesterday's Closing Price: $13.61 Daily Weekly Monthly
20 Day Moving Average: 34,621 shares
Shares Outstanding: 9.39 (millions)
Market Capitalization: $127.81 (millions)
Beta: 0.76
52 Week High: $17.75
52 Week Low: $9.83
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -5.88% -9.76%
12 Week 13.23% -0.78%
Year To Date -16.50% -21.14%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5214 S. 136TH STREET
-
OMAHA,NE 68137
USA		 ph: 402-991-5618
fax: -		 investor@fitlifebrands.com http://www.fitlifebrands.com
 
 • General Corporate Information   
Officers
Dayton Judd - Chief Executive Officer and Chairman
Jakob York - Chief Financial Officer
Grant Dawson - Director
Matthew Lingenbrink - Director
Todd Ordal - Director

Peer Information
FitLife Brands Inc. (BJCT)
FitLife Brands Inc. (CADMQ)
FitLife Brands Inc. (APNO)
FitLife Brands Inc. (UPDC)
FitLife Brands Inc. (IMTIQ)
FitLife Brands Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 33817P405
SIC: 2833
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 9.39
Most Recent Split Date: 2.00 (2.00:1)
Beta: 0.76
Market Capitalization: $127.81 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.26 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.06 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 12.84
Trailing 12 Months: 15.73
PEG Ratio: -
Price Ratios
Price/Book: 3.28
Price/Cash Flow: 13.43
Price / Sales: 2.00
EPS Growth
vs. Year Ago Period: -6.98%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -3.70%
vs. Previous Quarter: 6.15%
ROE
06/30/25 - -
03/31/25 - 25.59
12/31/24 - 27.88
ROA
06/30/25 - -
03/31/25 - 15.26
12/31/24 - 15.95
Current Ratio
06/30/25 - -
03/31/25 - 1.64
12/31/24 - 1.60
Quick Ratio
06/30/25 - -
03/31/25 - 0.72
12/31/24 - 0.62
Operating Margin
06/30/25 - -
03/31/25 - 14.14
12/31/24 - 14.22
Net Margin
06/30/25 - -
03/31/25 - 13.85
12/31/24 - 13.94
Pre-Tax Margin
06/30/25 - -
03/31/25 - 18.20
12/31/24 - 18.41
Book Value
06/30/25 - -
03/31/25 - 4.15
12/31/24 - 3.93
Inventory Turnover
06/30/25 - -
03/31/25 - 3.34
12/31/24 - 3.63
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.19
12/31/24 - 0.24
Debt-to-Capital
06/30/25 - -
03/31/25 - 16.04
12/31/24 - 19.14
 

Powered by Zacks Investment Research ©